Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • US Politics
    US Politics
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

Article Tools/Herramientas de artículos

+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña




Globe NewsWire News Distribution Service


Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Precision Neurodegenerative Disease Market, Global, 2024-2028" report has been added to ResearchAndMarkets.com's offering. The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique…


Posted: 2024-09-26 10:02:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related Bing News Search Results

Press Release: Precision Neurodegenerative Disease Global Market Report 2024-2028: Key Growth Opportunities in GLP-1 RA and Insulin for AD and PD Patients and Neurotech-based Precision Therapies - Newscast

Decreased levels of TDP-43 gene may be contributing to neurodegenerative diseases like Alzheimer's and ALS

Fri, 14 Mar 2025 08:19:04 GMT In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like ...

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

Thu, 13 Mar 2025 06:22:00 GMT AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today reported results for the full year ended December 31, ...

AC Immune to Participate in Upcoming Investor Conferences

Mon, 03 Mar 2025 23:00:00 GMT Lausanne, Switzerland, March 4, 2025 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative ... does not constitute a part of, ...

Unraveling stress granules: key to understanding neurodegenerative diseases

Mon, 03 Mar 2025 04:15:00 GMT However, the dysfunction of SGs has been implicated in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). While their role in ...

California Taxpayers Can Now Fund ALS and Neurodegenerative Disease Research through Voluntary Tax Contribution Fund

Mon, 24 Feb 2025 12:37:00 GMT LOS ANGELES, Feb. 24, 2025 /PRNewswire/ -- California has introduced a new initiative to advance critical research for ALS and related neurodegenerative diseases like Parkinson's, Alzeheimer's ...
Blow Us A Whistle




Related Product Search/Búsqueda de productos relacionados